Pulmonary Nocardiosis in the Immunocompetent Host: Case Series

Table 2

Patient demographics, predisposing condition, and treatment course.

	Case  1	Case  2	Case  3	Case  4
Age (years)	73	69	79	78
Sex	Female	Female	Female	Female
Predisposing condition	COPD and concurrent steroid use	Bronchiectasis	COPD and MAC colonization with bronchiectasis	MAC colonization
Pathogen	Nocardia cyriacigeorgica	Nocardia cyriacigeorgica	Nocardia cyriacigeorgica	Nocardia nova
Treatment	Trimethoprim/; Sulfamethoxazole	Inhaled Tobramycin and oral Linezolid	Trimethoprim/; Sulfamethoxazole	Observation
Duration	6 months	8 weeks	11 months	Continued observation

COPD: chronic obstructive pulmonary disease; MAC: Mycobacterium avium-intracellulare complex.